Parker Waichman LLP Headlines by Topic
Dexedrine
ADHD Drug Study Finds Heart Death Risks for Kids, But FDA Says Recommendations Won't Change
Jun 16, 2009
| Parker Waichman LLP
While a new study has found that stimulant medications used to treat attention-deficit hyperactivity disorder (ADHD) may increase the risk of sudden...
FDA Directs ADHD Drug Manufacturers to Notify Patients about Cardiovascular Adverse Events and Psychiatric Adverse Event
Feb 21, 2007
| www.fda.gov
The U.S. Food and Drug Administration (FDA) today directed the manufacturers of all drug products approved for the treatment of Attention Deficit...
Page 1/1
